D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Vertex Pharmaceuticals scored a major win with the EU approval of ALYFTREK, expanding its cystic fibrosis treatment access in ...

Most children with CF treated at a San Francisco CF clinic did not receive CF liver disease screening in accordance with current guidelines.

Without Medicaid, the level of care that Walter and other children like him require on an ongoing basis would be inaccessible to families. Yet that is what members of Congress are currently ...

Vertex Pharmaceuticals VRTX announced that the European Commission has approved Alyftrek ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

John William Crane was born on March 21, 1971, to Don and Libby Crane, and at the age of two years diagnosed with CF and ...

Vertex Pharmaceuticals secured EU approval for ALYFTREK, a next-gen cystic fibrosis therapy boasting a better efficacy ...

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best fundamental stocks to buy according to hedge funds. With a price target of $550, H.C.

WILMINGTON, N.C. (WECT) - ‘The Crossing’ is an international paddling challenge from Bimini, Bahamas to Lake Worth Beach, Florida. Organized by Piper’s Angel’s Foundation, ‘The Crossing’ helps those ...

Each of the Inevitable Foundation's five Accelerate Fellows will participate in a 6-month writing intensive and receive ...